UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Colorectal cancer in inflammatory bowel disease：What is the real magnitude of the risk

World journal of gastroenterology : WJG, 2012-08, Vol.18 (29), p.3839-3848

2012

Volltextzugriff (PDF)

The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines

Gut, 2018-09, Vol.67 (9), p.1568-1594

2018

Volltextzugriff (PDF)

British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis

Gut, 2019-08, Vol.68 (8), p.1356-1378

2019

Volltextzugriff (PDF)

Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging

Frontline Gastroenterology, 2014-07, Vol.5 (3), p.211-218

2014

Volltextzugriff (PDF)

The Serum Proteome and Ursodeoxycholic Acid Response in Primary Biliary Cholangitis

Hepatology (Baltimore, Md.), 2021-12, Vol.74 (6), p.3269-3283

2021

Volltextzugriff (PDF)

Network proximity analysis as a theoretical model for identifying potential novel therapies in primary sclerosing cholangitis

BMC medical genomics, 2024-06, Vol.17 (1), p.157-157

2024

Volltextzugriff (PDF)

Review article: unanswered clinical and research questions in autoimmune hepatitis‐conclusions of the International Autoimmune Hepatitis Group Research Workshop

Alimentary pharmacology & therapeutics, 2019-03, Vol.49 (5), p.528-536

2019

Volltextzugriff (PDF)

Bacterial and metabolic phenotypes associated with inadequate response to ursodeoxycholic acid treatment in primary biliary cholangitis

Gut microbes, 2023-12, Vol.15 (1), p.2208501-2208501

2023

Volltextzugriff (PDF)

Primary sclerosing cholangitis

The Lancet (British edition), 2018-06, Vol.391 (10139), p.2547-2559

2018

Volltextzugriff (PDF)

Neurosteroid Activation of GABA-A Receptors: A Potential Treatment Target for Symptoms in Primary Biliary Cholangitis?

Canadian journal of gastroenterology & hepatology, 2022, Vol.2022, p.3618090-13

2022

Volltextzugriff (PDF)

Fatal gastrointestinal histoplasmosis 15 years after orthotopic liver transplantation

World journal of gastroenterology : WJG, 2017-11, Vol.23 (43), p.7807-7812

2017

Volltextzugriff (PDF)

Understanding and Treating Fatigue in Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis

Clinics in liver disease, 2016-02, Vol.20 (1), p.131-142

2016

Volltextzugriff (PDF)

The relationship between disease activity and UDCA response criteria in primary biliary cholangitis: A cohort study

EBioMedicine, 2022-06, Vol.80, p.104068-104068, Article 104068

2022

Volltextzugriff (PDF)

How effective are experienced hepatologists at staging fibrosis using non‐invasive fibrosis tests in patients with metabolic dysfunction‐associated steatotic liver disease?

Alimentary pharmacology & therapeutics, 2024-07, Vol.60 (2), p.267-273

2024

Volltextzugriff (PDF)

Letter: Algorithmic NIT approaches to identify advanced liver fibrosis in patients with MASLD: Authors' reply

Alimentary pharmacology & therapeutics, 2024-10, Vol.60 (7), p.980-981

2024

Volltextzugriff (PDF)

Letter: Beyond advanced fibrosis—The critical need for assessing NITs performance in identifying F2‐F3 fibrosis. Authors' reply

Alimentary pharmacology & therapeutics, 2024-10, Vol.60 (7), p.976-977

2024

Volltextzugriff (PDF)

Liver toxicity associated with sofosbuvir, an NS5A inhibitor and ribavirin use

Journal of hepatology, 2016-01, Vol.64 (1), p.234-238

2016

Volltextzugriff (PDF)

The new epidemiology of primary biliary cirrhosis

Seminars in liver disease, 2014-08, Vol.34 (3), p.318-328

2014

Volltextzugriff (PDF)

UDCA prophylaxis for post-transplant PBC recurrence prevention: Time to change practice

Journal of hepatology, 2020-09, Vol.73 (3), p.499-501

2020

Volltextzugriff (PDF)

UK-Wide Multicenter Evaluation of Second-line Therapies in Primary Biliary Cholangitis

Clinical gastroenterology and hepatology, 2023-06, Vol.21 (6), p.1561-1570.e13

2023

Volltextzugriff (PDF)

Reply to “Liver failure in human immunodeficiency virus – Hepatitis C virus coinfection treated with sofosbuvir, ledipasvir and antiretroviral therapy”

Journal of hepatology, 2016-03, Vol.64 (3), p.753-754

2016

Volltextzugriff (PDF)

Pregnancy outcomes in women with liver transplants: systematic review and meta-analysis

HPB (Oxford, England), 2020-08, Vol.22 (8), p.1102-1111

2020

Volltextzugriff (PDF)

Pembrolizumab as a Cause of Cholangiopathy in a Patient With Metastatic Melanoma

Hepatology (Baltimore, Md.), 2020-06, Vol.71 (6), p.2164-2166

2020

Volltextzugriff (PDF)

Novel therapeutic targets in primary biliary cirrhosis

Nature reviews. Gastroenterology & hepatology, 2015-03, Vol.12 (3), p.147-158

2015

Volltextzugriff (PDF)

Adult parenteral nutrition in the North of England: a region-wide audit

BMJ open, 2017-01, Vol.7 (1), p.e012663-e012663

2017

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(44)

Publikationsform

Sprache

Englisch
(52)

Erscheinungsjahr

n.n

Thema

Science & Technology
(45)
Life Sciences & Biomedicine
(44)
Gastroenterology & Hepatology
(33)
Humans
(31)
Female
(14)
Male
(13)
Liver
(11)
Middle Aged
(11)
Patients
(11)
Hepatology
(10)
Liver Diseases
(10)
Risk Factors
(10)
Hepatitis
(9)
Aged
(8)
Liver Cirrhosis, Biliary - Drug Therapy
(8)
Ursodeoxycholic Acid - Therapeutic Use
(8)
Adult
(7)
Cholangitis
(7)
Cholagogues And Choleretics - Therapeutic Use
(6)
Gastroenterology
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Colorectal cancer in inflammatory bowel disease：What is the real magnitude of the risk

The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines

British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis

Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging

The Serum Proteome and Ursodeoxycholic Acid Response in Primary Biliary Cholangitis

Network proximity analysis as a theoretical model for identifying potential novel therapies in primary sclerosing cholangitis

Review article: unanswered clinical and research questions in autoimmune hepatitis‐conclusions of the International Autoimmune Hepatitis Group Research Workshop

Bacterial and metabolic phenotypes associated with inadequate response to ursodeoxycholic acid treatment in primary biliary cholangitis

Primary sclerosing cholangitis

Neurosteroid Activation of GABA-A Receptors: A Potential Treatment Target for Symptoms in Primary Biliary Cholangitis?

Fatal gastrointestinal histoplasmosis 15 years after orthotopic liver transplantation

Understanding and Treating Fatigue in Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis

The relationship between disease activity and UDCA response criteria in primary biliary cholangitis: A cohort study

How effective are experienced hepatologists at staging fibrosis using non‐invasive fibrosis tests in patients with metabolic dysfunction‐associated steatotic liver disease?

Letter: Algorithmic NIT approaches to identify advanced liver fibrosis in patients with MASLD: Authors' reply

Letter: Beyond advanced fibrosis—The critical need for assessing NITs performance in identifying F2‐F3 fibrosis. Authors' reply

Liver toxicity associated with sofosbuvir, an NS5A inhibitor and ribavirin use

The new epidemiology of primary biliary cirrhosis

UDCA prophylaxis for post-transplant PBC recurrence prevention: Time to change practice

UK-Wide Multicenter Evaluation of Second-line Therapies in Primary Biliary Cholangitis

Reply to “Liver failure in human immunodeficiency virus – Hepatitis C virus coinfection treated with sofosbuvir, ledipasvir and antiretroviral therapy”

Pregnancy outcomes in women with liver transplants: systematic review and meta-analysis

Pembrolizumab as a Cause of Cholangiopathy in a Patient With Metastatic Melanoma

Novel therapeutic targets in primary biliary cirrhosis

Adult parenteral nutrition in the North of England: a region-wide audit

Suchergebnisse filtern